CEO: Novavax to seek US authorization of its Covid vaccine in third quarter https://ift.tt/fJo911 The biotechnology company Novavax now plans to apply for emergency use authorization of its Covid-19 vaccine in the US in the third quarter of this year, CEO Stanley Erck told CNN in a phone interview on Monday.
